Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | PLXNA3 |
| Upstream (Parents) |
|---|
| (<<) ASNS → PLXNA3 |
| (<<) HMMR → PLXNA3 |
| (<<) FANCI → PLXNA3 |
| (<<) DDR1 → PLXNA3 |
| (<<) SEMA4D → PLXNA3 |
| Downstream (Children) |
|---|
| PLXNA3 → CADPS (>>) |
| PLXNA3 → RPL7P12///RPL7P32///RPL7P24///RPL7P20///RPL7P26///RPL7P23///RPL7P58///RPL7P8///RPL7P48///RPL7 (>>) |
| PLXNA3 → GABRE (>>) |
| PLXNA3 → TIAM1 (>>) |
| PLXNA3 → LOC157562 (>>) |
| PLXNA3 → SLC26A4 (>>) |
| PLXNA3 → TTC38 (>>) |
| PLXNA3 → PPP2R2B (>>) |
| PLXNA3 → ZNF580 (>>) |
| PLXNA3 → SLC22A4 (>>) |
